Recent research suggests that the activation of lipid biosynthesis (lipogenesis) is linked with prostate cancer (PCA) malignancy. Sterol regulatory element-binding protein-1 (SREBP-1) is a key transcriptional regulator controlling lipogenesis. Moreover, androgen receptor (AR) has been well defined to play an important role in lethal PCA aggressiveness from androgen-responsive to castration-resistant status. In this study, we showed that the quality-assured Ganoderma tsugae ethanol extract (GTEE), a Chinese natural and herbal product, significantly inhibited expression of SREBP-1 and its downstream genes associated with lipogenesis in PCA cells. Through inhibiting SREBP-1, GTEE reduced the levels of intracellular fatty acids and lipids in PCA cells. Importantly, GTEE also downregulated the expression of AR and prostate-specific antigen (PSA) in both androgen-responsive and castration-resistant PCA cells. By blocking the SREBP-1/AR axis, GTEE suppressed cell growth and progressive behaviors, as well as activating the caspase-dependent apoptotic pathway in PCA cells. These data provide a new molecular basis of GTEE for the development of a potential therapeutic approach to treat PCA malignancy.
CITATION STYLE
Huang, S. Y., Huang, G. J., Wu, H. C., Kao, M. C., & Huang, W. C. (2018). Ganoderma tsugae inhibits the SREBP-1/AR axis leading to suppression of cell growth and activation of apoptosis in prostate cancer cells. Molecules, 23(10). https://doi.org/10.3390/molecules23102539
Mendeley helps you to discover research relevant for your work.